LEF1 and neoplasm: Combined with the increase in DKK3 and MMP3 expression seen in tumor tissue, the demonstration of aberrant activation of LEF1 in the current study adds OSA to the range of cancers that exhibit aberrant Wnt activity [98,99,100,101].